Terumo (OTCMKTS:TRUMY) Shares Gap Up – Time to Buy?

Terumo Corp. (OTCMKTS:TRUMY)’s share price gapped up prior to trading on Friday. The stock had previously closed at $13.2545, but opened at $14.53. Terumo shares last traded at $14.3720, with a volume of 761,457 shares.

Analyst Upgrades and Downgrades

Separately, Nomura upgraded Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Terumo Price Performance

The stock’s 50-day moving average price is $15.13 and its 200-day moving average price is $14.19. The company has a market capitalization of $21.14 billion, a price-to-earnings ratio of 20.18 and a beta of 0.77. The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings results on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. The business had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.84 billion. Terumo had a net margin of 13.83% and a return on equity of 10.44%. Equities research analysts anticipate that Terumo Corp. will post 0.86 earnings per share for the current year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions.